www.standoutstocks.com: Stocks That Stand Out For Dec. 1st, 2009 Are CBPO, RFMD, EDWY, HTDS, CCTR

Visit Us On Twitter and Facebook: http://twitter.com/StandoutStocks http://www.facebook.com/people/Standout-Stocks/547603354 Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.Standoutstocks.com/" www.Standoutstocks.com

_________________________________________________

China Biologic Products Approved to List on NASDAQ

TAI'AN, China, Dec 01, 2009 -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (Nasdaq: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that the Company has received approval to list its common stock on the NASDAQ Global Market.

China Biologic expects its shares to begin trading on the NASDAQ on Wednesday, December 2, 2009, until which time its shares will continue to trade on the Over-the-Counter Bulletin Board. The Company's trading symbol will remain "CBPO." "We are very proud to have been approved to trade on the NASDAQ Stock Market and would like to thank our shareholders, employees, board of directors, and management team for helping us achieve this significant milestone," said Mr. Chao Ming Zhao, China Biologic's Chief Executive Officer. "We believe that our ascension to NASDAQ is a validation of our integrity and our commitment to sound corporate governance practices. We expect that the trading of our shares on NASDAQ will improve our visibility within the investment community, and lead toward increased liquidity and an expansion of our shareholder base." About China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state-owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China.

Safe Harbor Statement This release may contain certain "forward-looking statements" relating to the business of China Biologic Products, Inc. and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements," including statements regarding: the significance of the Company's listing on the NASDAQ Global Market; the ability of the Company to achieve its commercial objectives; the business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, and involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov ). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Shipments of RFMD's Industry-Leading 2G Transmit Module Surpass 25 Million, are Expected to Exceed 100 Million Units in Calendar 2010

RF71xx Family of 2G Transmit Modules Powering RFMD's Growth In Emerging Markets

GREENSBORO, N.C., Dec 1, 2009 -- RF Micro Devices, Inc. (Nasdaq:RFMD), a global leader in the design and manufacture of high-performance radio frequency components and compound semiconductor technologies, today announced that RFMD has surpassed 25 million units in shipments of its industry-leading RF71xx family of 2G dual-band and quad-band transmit modules. RFMD commenced volume shipments of the RF71xx product family in early calendar 2009, and shipments of RF71xx products currently exceed 20 million units per quarter.

Eric Creviston, president of RFMD's Cellular Products Group (CPG), said, "The success of the RF71xx product family has been central to RFMD's growth in 2G components and our expanding leadership in Asia. To date, RFMD has shipped RF71xx products to hundreds of customers in China, Taiwan and Korea, and the product family continues to enjoy robust design activity across handset manufacturers and global platform providers as we continue to develop specific product derivatives." Each product in the RF71xx product family is designed to meet the front end requirements of emerging market handsets, including reduced solution size, improved efficiency and robust ESD protection, while also satisfying customer requirements for quality, reliability and reduced handset bill-of-material (BOM) costs. RFMD's RF71xx transmit modules are pin-to-pin compatible across the entire product family, enabling customers to produce dual-band, tri-band or quad-band GPRS or EDGE handsets from a single handset platform -- an industry first.

About RFMD RF Micro Devices, Inc. (Nasdaq:RFMD) is a global leader in the design and manufacture of high-performance radio frequency components and compound semiconductor technologies. RFMD's products enable worldwide mobility, provide enhanced connectivity and support advanced functionality in the cellular handset, wireless infrastructure, wireless local area network (WLAN), CATV/broadband and aerospace and defense markets. RFMD is recognized for its diverse portfolio of semiconductor technologies and RF systems expertise and is a preferred supplier to the world's leading mobile device, customer premises and communications equipment providers.

Headquartered in Greensboro, N.C., RFMD is an ISO 9001- and ISO 14001-certified manufacturer with worldwide engineering, design, sales and service facilities. RFMD is traded on the NASDAQ Global Select Market under the symbol RFMD. For more information, please visit RFMD's web site at www.rfmd.com.

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" and similar words, although some forward-looking statements are expressed differently. You should be aware that the forward-looking statements included herein represent management's current judgment and expectations, but our actual results, events and performance could differ materially from those expressed or implied by forward-looking statements. We do not intend to update any of these forward-looking statements or publicly announce the results of any revisions to these forward-looking statements, other than as is required under the federal securities laws. RF Micro Devices' business is subject to numerous risks and uncertainties, including risks associated with the impact of global macroeconomic and credit conditions on our business and the business of our suppliers and customers, variability in operating results, the rate of growth and development of wireless markets, risks associated with the reduced investment in our wireless systems business, our ability to execute on our plans to consolidate or relocate manufacturing operations, our reliance on inclusion in third party reference designs for a portion of our revenue, our ability to manage channel partner and customer relationships, risks associated with the operation of our wafer fabrication facilities, molecular beam epitaxy facility, assembly facility and test and tape and reel facilities, our ability to complete acquisitions and integrate acquired companies, including the risk that we may not realize expected synergies from our business combinations, our ability to attract and retain skilled personnel and develop leaders, variability in production yields, raw material costs and availability, our ability to reduce costs and improve margins in response to declining average selling prices, our ability to bring new products to market, our ability to adjust production capacity in a timely fashion in response to changes in demand for our products, dependence on a limited number of customers, dependence on gallium arsenide (GaAs) for the majority of our products, and dependence on third parties. These and other risks and uncertainties, which are described in more detail in RF Micro Devices' most recent Annual Report on Form 10-K and other reports and statements filed with the Securities and Exchange Commission, could cause actual results and developments to be materially different from those expressed or implied by any of these forward-looking statements.

eDoorways Accelerates Platform's Web 3.0 Integration With Move to Drupal

Decision to Go "Open Source" With Drupal Will Accelerate Web 3.0 Functionality

AUSTIN, TX, Dec 01, 2009 -- The eDoorways Corporation (PINKSHEETS: EDWY | Quote | Chart | News | PowerRating) has chosen to rely on Drupal, an Open Source Content Management System written in PHP and distributed under the GNU General Public License, to expedite its Web 3.0 development and delivery of SOLVE version "Beta 2.0" which will include the first incarnation of the platform's mobile applications.

"Drupal is a globally established Open Source software with over 2 million downloads since 2001," stated Gary Kimmons, Chairman & CEO of eDoorways Corporation. "Open Source is indeed the future of the Internet." "Google's cell phone operating system Android is Open Source. The White House has just shifted the whitehouse.gov website to Drupal. The Defense Department's Chief Information Officer David Wennergren has put out a memo recently saying that Open Source software can be advantageous in pursuit of the military's missions." "Given all of the current uses people have for Drupal, the caliber of the organizations moving to Open Source, and the rigorous testing Drupal has undergone in the real world, it [Drupal] is clearly suited to eDoorways' ambitions. What's even more wonderful, through Drupal, the shift to Open Source doesn't slow down our development in the slightest. In fact, Drupal will accelerate not only the development of our Web 3.0 platform but also influence the early release of the more robust versions of the first doorway." Sources close to the company indicate that this move has always been a part of the original plan for eDoorways to establish an open API environment. This gives eDoorways an affiliation with many of those developers who are working on Web 3.0.

Kimmons continued, "Our plan has always been to pursue the Open Source alternative because it gives us increased flexibility and it will allow other developers to integrate into our system, bringing greater value to our service offerings. Drupal has proven itself to be a preferred software for us to use as we build our 3.0 platform and integrate each of our developing doorways into it. We are pursuing a pre-planned, step-by-step design approach that calls for this move at this time. It was originally designed into the development schedule we announced and it will play a large role in our upcoming release of SOLVE." Kimmons concluded, "Among supercomputers, 469 of the fastest 500 are running one kind of Linux or another, an Open Source operating system. eDoorways wants to capitalize on the advantages of Open Source software by building its platform with Drupal." With the company's first beta version of "SOVLE" on target for a mid December 09 release, people close to the company express much enthusiasm over Drupal as this development enhances the overall potential of additional versions of "SOLVE" slated for release during 2010: Beta 2.0, Beta 2.5, and the platform's "SOLVE" Version 3.0.

About eDoorways Corporation For more information on eDoorways Corporation and/or the "eDoorways" initiative, please e-mail a package request to info@eDoorwaysCorp.com. You can also visit our corporate website at www.eDoorwaysCorp.com, make comments via the corporate blog (www.eDoorways.wordpress.com), follow us on Twitter (http://twitter.com/edoorways), or call toll free at (866) 482-3829.

Safe Harbor Statements in this news release that are not historical facts, including statements about plans and expectations regarding products and opportunities, demand and acceptance of new or existing products, capital resources and future financial results are forward-looking. Forward-looking statements involve risks and uncertainties which may cause the Company's actual results in future periods to differ materially from those expressed. These uncertainties and risks include changing consumer preferences, lack of success of new products, loss of the Company's customers, competition and other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.

Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical

SHENZHEN, China, Nov 30, 2009 -- Hard to Treat Diseases' (HTDS; http://www.htdsmedical.com/) operating subsidiary Mellow Hope finalized contract details with one of the largest manufacturer of intravenous medication in India. This contract promises additional increase in revenues for Hard to Treat Diseases in the following quarters.

The contract between HTDS and the Indian company secures the supply of raw pharmaceutical material to the Indian pharmaceutical company in the range of about 1 million USD. Mellow Hope will be ready to release the shipments shortly. This contract is bound to strengthen Mellow Hope's sales and further increase the value of HTDS. HTDS' CEO Terry Yuan said, "With our earlier, 4 million USD deal with Indian Hetero Ltd. and our H1N1 vaccine deal with Chile, this is another great news for HTDS. Our business has truly grown in past few months and the investors must appreciate our achievements. With the world growing smaller and smaller, the vaccination market and industry are bound to grow bigger. That's the global trend, and HTDS is definitely a part of it." Hard to Treat Diseases (HTDS) is also a parent company with operations in Serbia based Slavica Biochem www.slavicabiochem.com. This company focuses on the enhancement and modification of existing and approved medications as well as on cancer research. The MindUp cancer research http://www.mindupbioresearch.com has been delivering groundbreaking results on the international level. The company expects to make some significant news announcement with a separate unrelated pharmaceutical company on this shortly.

To receive future updates, via email including quarterly newsletters and company updates which may not be newsworthy however important to the reader and followers of the company please sign up today free at www.minamargroup.com/updates Safe Harbor Statement Information in this news release may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be", "expects", "may affect", "believed", "estimate", "project" and similar words and phrases are intended to identify such forward-looking statements. Hard to Treat Diseases Inc. cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases Inc.'s control. In addition to those discussed in Hard to Treat Diseases Inc.'s press releases, public filings, and statements by Hard to Treat Diseases Inc.'s management, including, but not limited to, Hard to Treat Diseases Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases Inc.'s ability to raise additional capital to fund future operations, Hard to Treat Diseases Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match Hard to Treat Diseases Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

China Crescent Enterprises, Inc. Announces Exclusive Webcast to Update Suggested Fair Value Target Price Per Share Highlighting Near-Term Return Potential

Tuesday, December 1 Webcast Agenda Includes Recap of $30 Million in Revenue and Record $1.8 Million in Net Income for the Nine Months Ending September 30, 2009

DALLAS, TX, Nov 30, 2009 -- China Crescent Enterprises, Inc. (OTCBB: CCTR | Quote | Chart | News | PowerRating) has scheduled a shareholder update Webcast for Tuesday, December 1, 2009. The Webcast will feature an update of the suggested fair value target price per share highlighting the near-term return on investment (ROI) potential. Management believes the Company is undervalued with a current share price that reflects a market capitalization less than the current book value.

The Webcast agenda includes a review of the recently released letter to shareholders on the enhanced milestone ROI potential and improved long-term viability of China Crescent. The agenda further includes a recap of the Company's recently filed third quarter 2009 financial results. The Company reported $30 million in revenue through the first nine months of the year, ending September 30, 2009, and record net income of $1.8 million compared to $517k in net income for the same period in 2008. The Company has forecasted profitable revenue growth in 2009 compared to 2008. The Company reported over $40 million in profitable revenue in 2008. A link to the Webcast is scheduled to be posted to the corporate website homepage www.chinacrescent.com upon release.

Sign Up to Receive Regular China Crescent Investor Updates China Crescent sends regular email updates to its opt-in, permission-based email database. Interested investors can easily, safely and quickly register to receive these communications directly on the corporate website homepage (www.chinacrescent.com). Recipients can manage their own email contact profile and safely unsubscribe at any time.

About China Crescent Enterprises, Inc. (www.chinacrescent.com) China Crescent Enterprises, Inc. reported over $40 million in profitable revenue in 2008. The Company is a technology leader in the rapidly developing Chinese market specializing today in software engineering, high quality software development and digital multimedia outsourcing services delivered to customers globally. At the same time, the firm is a systems integrator and value added reseller of major global hardware brands in the Chinese domestic market.

Headquartered in Dallas with operations in Shanghai and Beijing, China Crescent bridges the gap between Western and Eastern business cultures to assist Western clients in realizing the advantages of the high quality, low cost technology products and services available from China. China Crescent also assists Western clients in localizing products and services to realize the tremendous growth potential available by expanding into the Chinese Market.

"SAFE HARBOR STATEMENT" UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause China Crescent's actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.

About Standoutstocks.com www.Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

www.Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at http://www.Standoutstocks.com and select the "join now" button.

Join us at http://www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: http://www.standoutstocks.com/disclaimer.aspx

CONTACT: Jason A. Hilton, Standout Stocks
Tel: +1 585 729 8809
e-mail: Jason@Newmediaadvisorsllc.com
e-mail: info@standoutstocks.com
WWW: http://www.standoutstocks.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on Rf Micro Devices Inc (RFMD) RFMD. Rf Micro Devices Inc (RFMD) has Short Term PowerRatings at TradingMarkets. Details on Rf Micro Devices Inc (RFMD) Short Term PowerRatings is available at This Link.

For full details on (CCSE) CCSE. (CCSE) has Short Term PowerRatings at TradingMarkets. Details on (CCSE) Short Term PowerRatings is available at This Link.

For full details on (EDWY) EDWY. (EDWY) has Short Term PowerRatings at TradingMarkets. Details on (EDWY) Short Term PowerRatings is available at This Link.

For full details on (CCTR) CCTR. (CCTR) has Short Term PowerRatings at TradingMarkets. Details on (CCTR) Short Term PowerRatings is available at This Link.